Project Grant R43NS134482
Award Date
9/20/23
Completion Date
8/31/24
Dollars Obligated
$291K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the...
This federal Project Grant award in the amount of $255,343 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a research study on the impact of phenylalanine elevations on metabolic, cognitive, and neural functioning in adults heterozygous for phenylketonuria (PKU). The study aims to conduct a double-blind crossover investigation comparing PKU carriers (n=18) and non-carriers...
This Project Grant award from the Food and Drug Administration (FDA) Research program (CFDA 93.103) provides $400,000.00 to The Children's Hospital of Philadelphia (CHOP) to accelerate clinical trials for Autosomal Recessive Polycystic Kidney Disease (ARPKD), a rare genetic disorder affecting children and young adults. The key objectives are to create a comprehensive patient registry called PKDNET that will collect natural history data, identify suitable clinical trial endpoints and prognostic...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports the development of a long-acting parathyroid hormone (PTH) derivative, EXT608, for the treatment of hypoparathyroidism. The $999,615 award to Extend Biosciences Inc., a woman-owned small business, will fund a Phase 2 clinical trial to evaluate the safety, tolerability, and efficacy of...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Omaroon Care under the Engineering (47.041) federal grant program. The grant supports the development of rapid and sensitive quantification of phenylalanine within test strips. The goal is to improve detection of phenylalanine levels, which is important for monitoring phenylketonuria. The one-year project period runs from March 2021 to February 2022 in Mission Viejo, California. The funding...
This $548,830 Project Grant awarded on August 1, 2024 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop and test a point-of-care device to predict the future development of severe acute kidney injury (AKI). The grantee, Nephsmart LLC, will leverage their discovery that extensive cleavage of a specific protein occurs in the urine of patients with mild AKI...
The federal Project Grant award SB1HD116629, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of a home-based device to accurately measure metabolite levels in individuals with rare metabolic disorders. Sequitur Health Corp, a for-profit company located in Scottsdale, Arizona, received $1,000,000.00 to perform late-stage development and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $321,363 to Nucleusrx, Inc. to develop and test a virtual care platform and remote intervention tool targeting post-acute care heart failure (HF) patients. The goal is to create a solution that enables healthcare providers to implement a safe discharge transition plan from hospital to home, while allowing rapid optimization of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $238,943 to Duke University to develop an automated platform for accurately tracking urine output in hospitalized heart failure patients. The key objectives are to: 1) validate the accuracy and timeliness of the device in measuring urine volume compared to conventional methods; 2) quantify the reduction in time lag between patient urination...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $459,097 to Pison Technology, Inc. to assess the company's neural biosensor as a scalable digital biomarker for characterizing disease progression in amyotrophic lateral sclerosis (ALS). The goal is to develop a wearable device that can remotely monitor physiological data from...